NASDAQ$HCAT
Health Catalyst Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Health Catalyst reported strong financial results with revenue of $73.8 million and Adjusted EBITDA of $2.0 million, exceeding guidance. The company raised full year 2023 revenue guidance and reiterated Adjusted EBITDA guidance. Team member engagement scores measured in the 94th percentile.
Health Catalyst reported strong Q3 2023 financial results, with total revenue of $73.8 million and Adjusted EBITDA of $2.0 million, both exceeding the midpoint of their quarterly guidance. They raised their full-year revenue guidance and reiterated their Adjusted EBITDA guidance. Team member engagement scores were also high, measured in the 94th percentile.
- Total revenue for Q3 2023 was $73.8 million.
- Adjusted EBITDA for Q3 2023 was $2.0 million.
- Full year 2023 revenue guidance range was raised.
- Full year 2023 Adjusted EBITDA guidance range was reiterated.
Headline financials
Revenue & EPS history
Health Catalyst · Revenue · Quarterly
$73.8M
Revenue by segment
Health Catalyst · $73.8M total across 2 segments · Q3 2023
- Technology$46M+4.5%62.3%
- Professional Services$27.8M+14.1%37.7%
Forward guidance
For Q4 2023, Health Catalyst expects revenue between $70.1 million and $75.1 million, and Adjusted EBITDA between $0.3 million and $2.3 million. For the full year 2023, they expect revenue between $291.0 million and $296.0 million, and Adjusted EBITDA between $10.0 million and $12.0 million.
Tailwinds
- Total revenue between $70.1 million and $75.1 million for Q4 2023.
- Adjusted EBITDA between $0.3 million and $2.3 million for Q4 2023.
- Total revenue between $291.0 million and $296.0 million for the full year 2023.
- Adjusted EBITDA between $10.0 million and $12.0 million for the full year 2023.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2023
-3.1%
Avg return
Earnings day
-3.9%
Avg return
5 days after
-4.0%
Avg return
30 days after
41%
11 / 27 earnings
Positive
+27.3%
Q2 2024
Best reaction
-36.6%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.9% | -21.7% | +4.6% | |
| Q4 2025 | -26.3% | -35.2% | -44.4% | |
| Q3 2025 | -5.6% | -20.5% | -10.2% | |
| Q1 2025 | +5.3% | +8.1% | +3.3% | |
| Q4 2024 | -11.1% | -8.5% | -7.9% | |
| Q3 2024 | +14.2% | +7.2% | +7.6% | |
| Q2 2024 | +27.3% | +7.3% | +22.9% | |
| Q1 2024 | -3.6% | +2.9% | -2.3% | |
| Q4 2023 | -14.7% | -8.9% | -14.4% | |
| Q3 2023 | +5.1% | -0.4% | +5.3% | |
| Q2 2023 | -8.0% | -5.0% | -12.4% | |
| Q1 2023 | -18.9% | -14.8% | -4.3% | |
| Q4 2022 | +7.3% | +5.8% | -14.8% | |
| Q3 2022 | +16.2% | +42.9% | +59.2% | |
| Q2 2022 | -36.6% | -34.7% | -35.9% | |
| Q1 2022 | -2.6% | +24.6% | +10.5% | |
| Q4 2021 | +1.5% | -7.1% | -3.7% | |
| Q3 2021 | -6.2% | -6.1% | -26.9% | |
| Q2 2021 | +1.5% | -2.3% | -2.8% | |
| Q1 2021 | -2.3% | -8.6% | -2.4% | |
| Q4 2020 | +0.6% | +0.1% | -2.1% | |
| Q3 2020 | -0.2% | -3.5% | +6.2% | |
| Q2 2020 | -7.2% | -10.9% | -3.4% | |
| Q1 2020 | -1.9% | -0.5% | -5.0% | |
| Q4 2019 | +1.3% | -5.8% | -20.1% | |
| Q3 2019 | +1.9% | -0.8% | -1.1% | |
| Q2 2019 | -11.5% | -7.8% | -13.1% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro